Compare · ILMN vs TRUP
ILMN vs TRUP
Side-by-side comparison of Illumina Inc. (ILMN) and Trupanion Inc. (TRUP): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both ILMN and TRUP operate in Medical Specialities (Health Care), so they compete in similar markets.
- ILMN is the larger of the two at $32.26B, about 25.2x TRUP ($1.28B).
- Over the past year, ILMN is up 116.8% and TRUP is down 37.3% - ILMN leads by 154.2 points.
- TRUP has been more active in the news (14 items in the past 4 weeks vs 8 for ILMN).
- ILMN has more recent analyst coverage (25 ratings vs 13 for TRUP).
- Company
- Illumina Inc.
- Trupanion Inc.
- Price
- $212.43-0.58%
- $28.23-3.07%
- Market cap
- $32.26B
- $1.28B
- 1M return
- +7.01%
- +13.35%
- 1Y return
- +116.82%
- -37.34%
- Industry
- Medical Specialities
- Medical Specialities
- Exchange
- NASDAQ
- NASDAQ
- IPO
- 2000
- News (4w)
- 8
- 14
- Recent ratings
- 25
- 13
Illumina Inc.
Illumina, Inc. provides sequencing and array-based solutions for genetic and genomic analysis. Its products and services serve customers in a range of markets enabling the adoption of genomic solutions in research and clinical settings for applications in the life sciences, oncology, reproductive health, agriculture, and other emerging segments. The company provides instruments and consumables used in genetic analysis; and genotyping and sequencing services, instrument service contracts, and development and licensing agreements. Its customers include genomic research centers, academic institutions, government laboratories, and hospitals, as well as pharmaceutical, biotechnology, commercial molecular diagnostic laboratories, and consumer genomics companies. The company markets and distributes its products directly to customers in North America, Europe, Latin America, and the Asia-Pacific region, as well as sells through life-science distributors in various markets within Europe, the Asia-Pacific region, Latin America, the Middle East, and Africa. It has a collaboration agreement with Geneseeq Technology Inc. to develop comprehensive in-vitro diagnostic (IVD) NGS testing kits for cancer. The company was incorporated in 1998 and is headquartered in San Diego, California.
Trupanion Inc.
Trupanion, Inc., together with its subsidiaries, provides medical insurance for cats and dogs on monthly subscription basis in the United States, Canada, Puerto Rico, and Australia. The company operates through Subscription Business and Other Business segments. It serves pet owners and veterinarians. The company was formerly known as Vetinsurance International, Inc. changed its name to Trupanion, Inc. in 2013. Trupanion, Inc. was founded in 2000 and is headquartered in Seattle, Washington.
Latest ILMN
- Director Meister Keith A. sold $85,241,664 worth of shares (375,941 units at $226.74) (SEC Form 4)
- Director Meister Keith A. sold $145,556,398 worth of shares (679,574 units at $214.19) (SEC Form 4)
- SVP, Strategy/Corp Development Wedel Christensen Jakob sold $197,840 worth of shares (1,033 units at $191.52), decreasing direct ownership by 7% to 14,023 units (SEC Form 4)
- SEC Form 8-K filed by Illumina Inc.
- Illumina Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Termination of a Material Definitive Agreement, Creation of a Direct Financial Obligation, Financial Statements and Exhibits
- SEC Form 8-K filed by Illumina Inc.
- SEC Form 3 filed by new insider Coletti Julie Ann
- SEC Form FWP filed by Illumina Inc.
- Chief Commercial Officer Sullivan Michael C was granted 4,503 shares (SEC Form 4)
- Illumina Inc. filed SEC Form 8-K: Other Events, Financial Statements and Exhibits
Latest TRUP
- CEO Tooth Margaret converted options into 19,042 shares, covered exercise/tax liability with 7,000 shares and sold $15,633 worth of shares (491 units at $31.84), increasing direct ownership by 7% to 186,952 units (SEC Form 4) (withholding tax)
- Director Rubin Howard E converted options into 420 shares, increasing direct ownership by 0.18% to 233,288 units (SEC Form 4)
- Director Powell Bradley S converted options into 1,640 shares, increasing direct ownership by 86% to 3,546 units (SEC Form 4)
- Chief Legal Officer Bearman Asher converted options into 2,610 shares and covered exercise/tax liability with 841 shares, increasing direct ownership by 2% to 74,013 units (SEC Form 4) (for tax liability)
- Chief Administration Officer Mcgibney Brenna converted options into 6,430 shares and covered exercise/tax liability with 3,438 shares, increasing direct ownership by 26% to 14,437 units (SEC Form 4) (tax withholding)
- Chief Operating Officer Gallagher John R converted options into 6,794 shares and covered exercise/tax liability with 1,651 shares, increasing direct ownership by 16% to 37,346 units (SEC Form 4) (tax liability)
- EVP, North Am & Vet Strategy Weinrauch Steve converted options into 4,859 shares and covered exercise/tax liability with 1,181 shares, increasing direct ownership by 5% to 81,740 units (SEC Form 4) (withholding tax)
- Director Rawlings Darryl converted options into 313 shares, increasing direct ownership by 1% to 25,151 units (SEC Form 4)
- Chief Financial Officer Qureshi Fawwad converted options into 13,746 shares, covered exercise/tax liability with 5,486 shares and sold $183,391 worth of shares (6,111 units at $30.01), increasing direct ownership by 103% to 4,230 units (SEC Form 4) (for withholding tax)
- EVP, Trupanion International Wheeler Simon converted options into 2,173 shares and covered exercise/tax liability with 1,085 shares, increasing direct ownership by 4% to 25,327 units (SEC Form 4) (for tax liability)